HPGC(SH:600664)2016-04-29 16:00Financial Performance - Operating revenue for the current period was CNY 3,451,755,671.97, representing a decline of 29.16% year-on-year[6] - Net profit attributable to shareholders was CNY 97,383,313.17, down 39.91% from the same period last year[6] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 75,861,180.03, a decrease of 51.06% year-on-year[6] - Basic and diluted earnings per share were both CNY 0.04, down 42.86% compared to the previous year[6] - The company reported a net profit for Q1 2016 of CNY 108,910,560.62, a decline of 37.7% compared to CNY 175,047,299.37 in Q1 2015[28] - The net profit attributable to shareholders of the parent company was CNY 97,383,313.17, down 40.0% from CNY 162,059,107.56 in the previous year[29] - The company reported an operating profit of CNY 121,524,541.39 for Q1 2016, down 44.7% from CNY 219,851,926.18 in Q1 2015[28] Cash Flow - The company generated a net cash flow from operating activities of CNY 1,034,909,621.37, compared to a negative cash flow of CNY -233,730,990.46 in the same period last year[6] - Cash flow from operating activities for Q1 2016 was ¥1,034,909,621.37, an increase from a negative cash flow of ¥233,730,990.46 in Q1 2015, attributed to changes in sales policies and an increase in cash sales[14] - The company's operating cash flow for Q1 2016 was CNY 1,034,909,621.37, a significant improvement compared to a negative cash flow of CNY -233,730,990.46 in the same period last year[33] - Total cash inflow from operating activities reached CNY 4,294,762,299.10, up from CNY 3,592,001,850.50 in Q1 2015, representing an increase of approximately 19.6%[33] - Cash outflow for purchasing goods and services decreased to CNY 1,948,616,546.20 from CNY 2,413,916,520.74, a reduction of about 19.3% year-over-year[33] - The company reported a net increase in cash and cash equivalents of CNY 1,033,329,265.68, recovering from a decrease of CNY -314,056,684.37 in Q1 2015[34] - The ending balance of cash and cash equivalents was CNY 2,853,098,533.61, up from CNY 2,020,395,799.80 at the end of Q1 2015[34] Assets and Liabilities - Total assets at the end of the reporting period were CNY 13,572,955,753.52, a decrease of 1.40% compared to the end of the previous year[6] - Current assets totaled ¥8,278,499,769.49, a slight decrease of 0.77% from the beginning of the year[20] - Total liabilities decreased to ¥6,032,279,300.43, down 3.98% from ¥6,283,002,510.50[22] - Total liabilities as of the end of Q1 2016 amounted to CNY 5,446,123,508.25, an increase of 3.1% from CNY 5,282,331,817.16 at the end of the previous year[28] - Owner's equity increased to ¥7,540,676,453.09, up 0.77% from ¥7,483,006,197.63[22] - Total equity increased to CNY 5,226,019,142.94 in Q1 2016, up from CNY 5,184,427,372.91 in the same period last year[28] Shareholder Information - The total number of shareholders at the end of the reporting period was 57,682[9] - The largest shareholder, Harbin Pharmaceutical Group Co., Ltd., held 902,441,450 shares, accounting for 47.06% of the total shares[9] Capital and Reserves - The company completed a capital reserve conversion to increase its share capital, raising the total share capital from 1,917,483,289 shares to 2,492,728,276 shares[6] - The capital reserve decreased by 51.79% to ¥535,549,152.67, from ¥1,110,794,139.67, mainly due to the capital reserve being converted into share capital[13] - The company reported a total of ¥1,285,223,044.53 in surplus reserves, unchanged from the previous period[22] Expenses - Sales expenses for Q1 2016 were ¥228,880,640.22, a decrease of 54.43% from ¥502,246,950.48 in Q1 2015, due to adjustments in marketing policies[14] - The company's financial expenses decreased by 70.03% to -¥2,864,534.62, compared to -¥9,557,040.71 in the previous year, primarily due to reduced interest income[14]